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Introduction: The authors carried out a retrospective assessment of the efficacy of CryoMaze
procedure employed between early 2004 and June 2011 jointly with performing other
cardiac surgeries in patients suffering permanent/persistent or paroxysmal Atrial
Fibrillation (AF) and other supraventricular arrhythmias. Included in the set to be assessed
were 383 patients. This paper aims to assess the effectiveness of the procedure in
maintaining the Sinus Rhythm (SR).
Methods: Within one year following the discharge from the Center, the patients, then
outpatients, underwent four follow-up checks – data obtained in the checks have been used
to compile this assessment.
Conclusion: One year after the CryoMaze therapy was given, 74% of the patients exhibited
sinus rhythm. No complications attributable to the use of cryoenergy were observed. The
best results in restoring and maintaining the sinus rhythm were achieved in the group of
patients indicated for CryoMaze because of their paroxysmal atrial fibrillation.
& 2012 The Czech Society of Cardiology. Published by Elsevier Urban & Partner Sp.z.o.o. All
rights reserved.1. Introduction
Atrial fibrillation is the most frequently encountered sus-
tained cardiac arrhythmia. Its prevalence is constantly on the
rise. The condition is characteristic of fast uncoordinated
atrium activation translated into the deterioration of atrial
mechanical function and the increased risk of thrombo-
embolic events [1]. AF impairs the quality of life and raises
both morbidity and mortality [2]. That is why the optimal
treatment of AF patients is ceaselessly sought.ch Society of Cardiology.
5.
).2. Epidemiology
Prevalence of AF in adults is reported to be kept between 0.95%
and 2%. The figure oscillates from 0.1% in persons below 55 years
of age to 3.8% in people over 60 and to 9.0% in the octogenarians
and above. Atrial fibrillation is on the increase and for the next
50 years the number of AF patients is expected to multiply from
2.5-fold to 5-fold. Approximately 85% of AF patients are older
than 65. Males develop the condition more frequently than
females (1.1% prevalence as compared to 0.8%) [3]. Patients withPublished by Elsevier Urban & Partner Sp.z.o.o. All rights reserved.
Fig. 1 – Electro-physiological representation of the Cox-maze
III procedure, described in text above the figure (PV –
Pulmonary Veins; IVC – Inferior Vena Cava; SVC – Superior
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the failure: it starts at about 5% for patients in NYHA I Class and
finishes at almost 50% for NYHA IV Class patients [4]. Atrial
fibrillation is most often associated with valvular defects,
particularly the mitral defects, and the ischemic heart disease;
it is frequently seen in patients with heart failure and hyperten-
sion. Patients undergoing mitral valve surgery exhibit atrial
fibrillation in as much as 50% of cases [5–8].
Mortality of AF patients is about twice as high as that
observed in patients with the sinus rhythm. The higher rates
of morbidity and mortality witnessed in AF patients can be
ascribed primarily to the increased occurrence of thrombo-
embolic events. In cases where the AF acts jointly with a
valvular defect (especially the mitral regurgitation), the risk of
ictus can be increased 17-fold [9].
Vena Cava; SAN – Sinoatrial Node; AVN – Atrioventricular
Node; RAA – Right Atrial Appendage; LAA – Left Atrial
Appendage).
Fig. 1 used from: Nitta, T., Lee, R., Schuessler, RB., Boineau, JP,
Cox, JL. Radial approach: a new concept in surgical treatment
for atrial fibrillation I. Concept anatomic and physiologic
bases and development of a procedure. Ann Thorac Surg,
1999, 67, p. 27–35.3. Pathophysiology of atrial fibrillation
Theories formulated to explain the mechanism of AF devel-
opment assume the existence of one or multiple ectopic foci
and the presence of one or several re-entrant circuits. Often
enough AF is triggered by impulses repeatedly transmitted
from the ectopic foci. Such impulses can appear as single
occurrences; in bursts; or, rarely, as impulses of very high
frequency (the truly focal AF). There can be a single focus or
several foci – if several, the foci can take turns in activating.
Most frequently the foci are located at the orifices of pulmo-
nary veins, specifically in the ‘‘sleeves’’ of the atrial muscles
extended over the veins [10]. As presumed, the triggering
function of ectopy is at work at the early stages of the
paroxysmal AF, while the remodeled atrium offers conditions
favorable for maintaining re-entry. The theory of multiple
re-entries suggests that AF is maintained by the action of
several unstable circuits subdivided into sub-circuits of multi-
ple levels, whose number will depend on the size and con-
ductive properties of the atrium. If the AF is to be maintained,
4 to 7 circuits are considered a sine qua non. The greater the
atrial dilatation, the higher the probability of AF (the reason
being that more circuits can be ‘‘crammed’’ in the atrium and
thus changed). Special importance can be attached to the left
atrium which has circuits around the orifices of pulmonary
veins. Both the catheter and the surgery methods of curing AF
are applied to disintegrate the re-entrant circuits.4. Therapy
Atrial fibrillation has to be treated in an individualized
manner. Broadly stated, the treatment targets the arrhythmia
proper and at the same time it endeavors to prevent the
thrombo-embolic events. The AF therapy itself is oriented in
two directions: the first one tries to restore and maintain the
sinus rhythm (the rhythm control), while the other attempts
to optimize the heartbeat frequency during the permanent AF
(the frequency control).
Pharmacological therapy: rhythm/ frequency control and
thrombo-embolism prevention. Non-pharmacological therapy:
electrical cardioversion, cardio-stimulation, catheter ablation
and surgery ablation also known as the MAZE procedure.MAZE (a labyrinthine network of pathways)—the first type of
the MAZE procedure was developed in the late 1980s by
professor Cox and his team whose Cut and Sew technique
yielded very good results in maintaining the sinus rhythm.
Since then the method has undergone several modifications
finally resulting in the modified type of MAZE III as applied
today. MAZE III is a system of transmural lesions carried out in
heart atria and designed to make sure the impulse travels from
the SA node to the AV node through the only route available,
concurrently spreading into numerous blind branches. Such
intervention should enable homogenous contraction of all
areas of atrial myocardium, an action perceived as a funda-
mental prerequisite for recovery of their transportation func-
tion. Intervention in the left atrium: isolating the pulmonary
vein orifices; joining the right-side and left-side pulmonary
veins; making a line to the mitral annulus and across sinus
coronarius, (eventually) resection of atrial apenndage. Inter-
vention in the right atrium: performing a series of linear
incisions towards the superior vena cava and the inferior vena
cava; making a line towards the cavotricuspid isthmus; and
making a line towards the septum. Epi- or endo-cardial course
depends on if the atrium is opened (especially in the valvular
surgery). Modified Cox MAZE III with isolating the pulmonary
vein orifices; joining the right-side and left-side pulmonary
veins; making a line to the mitral annulus and across sinus
coronarius, is nowadays using at most, because it is leading to
minimal decrement of effectivity of the procedure, but it
decrements significantly the operation complexity (Fig. 1).
At present the Department of Cardiosurgery in Cˇeske
Budeˇjovice performs these types of MAZE interventions MAZE conducted while operating on cardiac blood vessels
or valves from sternotomy – cryoablation; MAZE conducted while operating on mitral or mitral and
tricuspid valve from right-handed minithoracotomy –
cryoablation;
Table 1 – Characteristic of the set.
Number of
patients
[%] of the
entire set
Diabetes 320 83.5
Hypertension 353 92.2
Renal insufficiency 70 18,3
IHD (Ischemic Heart Disease) 202 52.8
COPD (Chronic Obstructive
Pulmonary Disease)
67 17.5
Previous cardiosurgeries 5 1.3
Table 2 – Types of the procedures.
Single left-sided CryoMaze 143
Both-sided CryoMaze 240
Endocardial CryoMaze 124
Epicardial CryoMaze 259
Resecting the left atrium appendage 60
Reducing the left atrium 6
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AF from right-handed minithoracotomy (possibly per-
formed jointly with resecting/ suturing the left atrium
appendage and reducing the left atrium size) – cryoablation; Endoscopic MAZE conducted as an isolated surgery in the
treatment of AF is performed from right-handed mini-
thoracotomy – radiofrequency (RF) ablation.
Included in the statistical set were patients who underwent
the Maze procedure together with another cardiosurgery
between March 2004 and June 2011 – throughout the next
year they were checked as outpatients in our Department.5. Characteristic of the set of patients
The intraoperative cryomaze procedure was performed on
383 patients, 69 years of age on average, out of whom 152
(40%) were females.
Before the intervention 236 (61.6%) of the patients suffered
the permanent atrial fibrillation, the paroxysmal or persistent
AF was observed in 115 (30.1%) patients and the atrial flutter
in 18 (4.7%) of the patients. As obvious from the transthoracic
echocardiogram, the average systolic dimension of the left
atrium (when measured in the parasternal projection onto
the long axis) was 48.177 mm, while the average ejection
fraction of the left ventricle was 55% (Table 1).6. Surgeries performed jointly with the
CryoMaze procedure
Isolated aortic-coronary artery bypass was carried out in 153
patients (39.9% of the total number); the mitral valve was
operated on in 80 patients (20.9%); 30 cases were treated with
replacement therapy; and 50 cases were treated with plastic
surgery of the mitral valve. Concurrent surgeries of the mitral
and tricuspid valves were performed in 101 (26.4%) patients,
while 106 (26.7%) persons underwent the isolated surgery of
the aortic valve.
Table 2 shows the types of MAZE procedures, possibly
applied together with the resection or suture of appendage;
in 6 cases the MAZE procedure was accompanied by an
intervention designed to reduce the left atrium.7. Methodics of monitoring
With the CryoMaze performed and the patients discharged,
Warfarin anticoagulation therapy is indicated for a period no
shorter than 3 months; a beta blocker is used as an anti-
arrhythmic drug; if the postoperative relapse of AF is treated
with amiodarone, propafenone and other antiarrhythmic
drugs (digitalis, sotalol) are administered to a substantially
reduced number of patients.
One month after the surgery all patients go through a
follow-up examination wherein they have their ECG recorded
and the therapy attuned to their condition. Patients subjected
to CryoMaze are then examined 3, 6 and 12 months after the
surgery. Coming to be checked after 3 months, the patients
bring in the results of 24-hour ECG monitoring, they have
their clinical condition reexamined and the transthoracic
echocardiogram recorded to see especially if the atrial Awave
is present. With the sinus rhythm maintained, the AF
obviously not relapsing, and the atria provably contracting,
the anti-coagulation therapy is terminated and the patients
are put on anti-aggregation treatment.8. Results
On discharge from hospital, the sinus rhythm (SR) was
detected in 66% of patients; after 3 months the figure was
72%; after 6 months is was 68% and after 12 months 75%. The
best results were achieved in a subgroup of patients suffering
the paroxysmal AF (82% on discharge and 89% after one year
of monitoring); the worst results were obtained in a subgroup
of patients having the left atrium preoperatively dilated (57%
on discharge, 62% after one year).
As regards postoperative complications, 8 patients (2.09%)
had to be revised for early postoperative bleeding. Twenty five
patients (6.5%) were indicated for permanent cardiac stimula-
tion early after the surgery (7th to 15th day). 18 hospitalized
patients experienced a cerebrovascular event, out of whom 14
had a Transient Ischemic Attack (TIA) without any subse-
quent neurological deficit and 4 developed an ictus followed
by a persisting neurological deficit. The average time spent at
the Resuscitation Ward (RES) was 4.6 day, while the average
time-to-discharge from the Department was 14.6 day. Twenty
nine patients (7.5%) died at the early postoperative period
(within 30 day of surgery).
When monitored as outpatients, 28 more patients were
indicated for permanent cardiac stimulation. Throughout
the one-year monitoring 4 patients underwent catheter
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Diagram 1 – Success rate of restoring and maintaining the
sinus rhythm: red column indicates total number of patients
with sinus rhytm by each ambulant control( discharged
from hospital, 1st month control, 3rd, 6th and after 12th
month), green column patients with permanent AF before
the operation, blue column with paroxysmal and purple
column patients with dilated left atrium over 50 mm
(measured from parasternal projection to long axis).
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treat relapsing AF; and 2 patients had to have their AV node
ablated and then a pacemaker implanted. Another 9 patients
died – the available documentation was not allowed to
identify the causes (Diagram 1).9. Discussion
Patients suffering permanent or paroxysmal AF have not been
investigated in many prospective randomized studies wherein
the different cardiosurgery interventions accompanied by
intraoperative ablation would be compared with a control
group in which no form of ablation was performed. If available
at all, the randomized data do not cover large groups of
patients, and the patients actually included are exclusively
those who have their mitral valves diseased [11–18].
The papers mentioned above testify quite unambiguously
to the beneficial effect that surgical ablation has on main-
taining the sinus rhythm (SR) after mitral valve interventions.
The higher rate of SR maintained in the intervened group
then translated itself into a positive effect on thrombo-
embolic events. The quoted papers report that the group of
patients who underwent the ablation maintained SR in 44.4%
to 95.2% of cases, while the not ablated group exhibited the SR
maintenance in 4.5% to 42.9% of cases [19]. The differences
were statistically significant in all sets of the patients.
Currently the left or right atrial appendage is resected or
sutured while performing the CryoMaze solely in cases where
a thrombus is documentably contained in the appendage; a
spontaneous echo-contrast is present; and/or a cerebrovas-
cular event is recorded in the anamnesis.
Concerning the energy, in conducting intraoperative MAZE
the authors rely exclusively on cryoenergy. The cryoablation,
in contrast to radiofrequency, generally keeps the collagenous
tissue integrated. During 48 h after the procedure irreversible
lesions develop in the form of hemorrhages, oedemas and
inflammations. Throughout 12 weeks from the cryoablationthe atrial wall develops a transmural homogenous and
fibrotic lesion. A major benefit of the cryoenergy rests in its
capability of maintaining the tissue structures integral and
the thrombogenesis at a low level (20).
The herein presented set of patients with preoperatively
diagnosed atrial fibrillation, who underwent cryoablation
together with another cardiac surgery, exhibited long-term
and high-level effectiveness in maintaining the sinus rhythm.
Our results can be favorably compared with those published
in literature.
In accordance with results published elsewhere, our set of
patients also manifested marked improvement within the
first six months after the intervention, whereas the later
improvements were more moderate. Consequently, the sub-
sequent interventions made with reliance on pharmacologi-
cal or electrical cardioversions were most successful when
completed during the first months after the operation.
The use of cryoablation did not heighten the perioperative
risk, and the early mortality figure (7.5%) was comparable with
that encountered after cardiosurgeries conducted without
cryomaze. Analogously to what has to be done after catheter
ablation for AF, some of the patients had to be kept on the
antiarrhythmic therapy, primarily to suppress the early relap-
sing arrhythmias experienced before the atria were fully healed.
Residual arrhythmogenic substrate left after the surgical
cryoablation may occasionally require that antiarrhythmic
drugs be administered in the course of subsequent monitor-
ing, but even in such cases the intervention will often make
effective a therapy which would otherwise be incapable of
maintaining the sinus rhythm [21].10. Limitations
Asymptomatic AF events not obvious in the electrocardio-
gram can now and then occur within the period of monitor-
ing. The assessments of results relied on anamnesis focused
on arrhythmia symptoms and standard ECG methods,
including the 24-hour Holter ECG monitoring.11. Conclusion
The surgical cryoablation has proved to be a safemethod of long-
term effectiveness available to treat atrial fibrillation in patients
undergoing another cardiosurgery; the method offers a high
probability of restoring the sinus rhythm and allows to reduce
the subsequent antiarrhythmic and anticoagulation therapy.
Currently surgical cryoablation is a standard therapy applicable
both to permanent and to paroxysmal atrial fibrillation.
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